MedPath

Long-term Prognosis of Emergency Aneurysmal Subarachnoid Hemorrhage

Recruiting
Conditions
Aneurysmal Subarachnoid Hemorrhage
Interventions
Procedure: Surgical clipping and endovascular coiling
Registration Number
NCT04785976
Lead Sponsor
Beijing Tiantan Hospital
Brief Summary

Rupture of intracranial aneurysms can lead to extensive subarachnoid hemorrhage (SAH), a potentially fatal neurological emergency with mortality rates ranging from 8 to 67%. At present, surgical clipping (SC) and endovascular coiling (EC) are two main treatments for aneurysmal subarachnoid hemorrhage (aSAH), in recent years, the improvements in surgical equipment and techniques have already greatly improved the postoperative safety of patients. However, considering individual differences between patients, some still at risk due to possible complications during hospitalization or after discharge from the hospital, it will no doubt generate a large healthcare burden.

This prospective, observational clinical trial (LongTEAM) is to improve the diagnosis and treatment effect and efficiency in this field, reducing mortality, medical costs, and medical burden, while opening up new avenues for interdisciplinary clinical practice and scientific research exploration.

Detailed Description

Not available

Recruitment & Eligibility

Status
RECRUITING
Sex
All
Target Recruitment
5000
Inclusion Criteria
  • All patients admitted to the emergency department of the investigator with aneurysmal subarachnoid hemorrhage are included in their prospective registry.
Exclusion Criteria
  • None

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Arm && Interventions
GroupInterventionDescription
Endovascular coilingSurgical clipping and endovascular coiling-
Surgical clippingSurgical clipping and endovascular coiling-
Primary Outcome Measures
NameTimeMethod
Unfavorable neurological outcome (mRS>2)24 months

Number of patients experiencing a unfavorable neurological outcome at 24 months post-treatment, defined as a modified Rankin Scale (mRS) score of \>2.

Secondary Outcome Measures
NameTimeMethod
Cognitive deficits24 months

Number of patients experiencing a unfavorable neurological outcome at 24 months, defined as changes in thinking, emotion, will and behavior.

Major adverse cardiac or cerebrovascular events24 months

Number of patients experiencing an event including all-cause death, non-fatal cerebrovascular event, non-fatal any myocardial infarction and revascularization at 24 months.

Trial Locations

Locations (2)

Beijing Tiantan Hospital

🇨🇳

Beijing, Beijing, China

The First People's Hospital of Neijiang

🇨🇳

Neijiang, Sichuan, China

© Copyright 2025. All Rights Reserved by MedPath